# NYPOZI txid

NDC: 72374-101
Generic name: filgrastim-txid
Labeler / Manufacturer: Tanvex BioPharma USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20250923

FDA application: BLA761126

## Active ingredients

- FILGRASTIM: 300 ug/300ug

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72374-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72374-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89092bb8-6a20-e23e-e053-2a95a90aa750